1st Global Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$712K Sell
4,971
-129
-3% -$17.3K 0.08% 204
2017
Q1
$639K Buy
5,100
+221
+5% +$25.6K 0.07% 223
2016
Q4
$550K Sell
4,879
-44
-0.9% -$5.1K 0.07% 244
2016
Q3
$633K Sell
4,923
-201
-4% -$24.1K 0.08% 209
2016
Q2
$560K Sell
5,124
-549
-10% -$54.6K 0.08% 222
2016
Q1
$538K Buy
5,673
+1,265
+29% +$107K 0.08% 230
2015
Q4
$398K Sell
4,408
-715
-14% -$60.7K 0.06% 248
2015
Q3
$475K Buy
5,123
+972
+23% +$85.6K 0.08% 209
2015
Q2
$273 Sell
4,151
-2,602
-39% -$173K 0.04% 361
2015
Q1
$483K Sell
6,753
-999
-13% -$54.2K 0.07% 220
2014
Q4
$295K Sell
7,752
-613
-7% -$19.3K 0.04% 326
2014
Q3
$208K Buy
+8,365
New +$212K 0.03% 409
2014
Q2
Sell
-8,162
Closed -$213K 457
2014
Q1
$213K Buy
+8,162
New +$226K 0.04% 378

Other funds holding ABMD

1st Global Advisors's ABMD Position: Q2 2017 in Review

1st Global Advisors reduced its Abiomed Inc (ABMD) stake by 2.5% in Q2 2017, selling an estimated $17.3K and leaving 4,971 shares worth $712K. The position accounts for 0.08% of the portfolio, ranked #204.

1st Global Advisors first reported a position in ABMD in Q1 2014 and has held it in 13 quarters since. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • 1st Global Advisors held 4,971 shares of Abiomed Inc worth $712K as of Q2 2017.
  • 1st Global Advisors sold 129 Abiomed Inc shares in Q2 2017, an estimated $17.3K.
  • Abiomed Inc made up 0.08% of 1st Global Advisors's portfolio in Q2 2017, its #204 holding.
  • 1st Global Advisors first reported a position in Abiomed Inc in Q1 2014 and has held it in 13 quarters since.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.